CY1120438T1 - Φαρμακευτικη συνθεση που περιλαμβανει μυο-ινοσιτολη και d-κιρο-ινοσιτολη - Google Patents

Φαρμακευτικη συνθεση που περιλαμβανει μυο-ινοσιτολη και d-κιρο-ινοσιτολη

Info

Publication number
CY1120438T1
CY1120438T1 CY20181100743T CY181100743T CY1120438T1 CY 1120438 T1 CY1120438 T1 CY 1120438T1 CY 20181100743 T CY20181100743 T CY 20181100743T CY 181100743 T CY181100743 T CY 181100743T CY 1120438 T1 CY1120438 T1 CY 1120438T1
Authority
CY
Cyprus
Prior art keywords
inositol
kiro
pharmaceutical composition
composition containing
quirinositol
Prior art date
Application number
CY20181100743T
Other languages
English (en)
Inventor
Vittorio Unfer
Original Assignee
Lo. Li. Pharma S.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45540947&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1120438(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lo. Li. Pharma S.R.L. filed Critical Lo. Li. Pharma S.R.L.
Publication of CY1120438T1 publication Critical patent/CY1120438T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Abstract

Αυτή είναι μια περιγραφή φαρμακευτικών συνθέσων που περιλαμβάνουν ινοσιτόλη και D-κιροινοσιτόλη σε συγκεκριμένες αναλογίες, χρήσιμες για τη θεραπεία του PCOS και για τη βελτίωση της ποιότητας των ωοκυττάρων γενικότερα.
CY20181100743T 2011-11-22 2018-07-17 Φαρμακευτικη συνθεση που περιλαμβανει μυο-ινοσιτολη και d-κιρο-ινοσιτολη CY1120438T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000252A ITFI20110252A1 (it) 2011-11-22 2011-11-22 Composizione farmaceutica comprendente myo-inositolo e d-chiro-inositolo.
PCT/EP2012/073189 WO2013076121A1 (en) 2011-11-22 2012-11-21 Pharmaceutical composition comprising myo-inositol and d-chiro-inositol

Publications (1)

Publication Number Publication Date
CY1120438T1 true CY1120438T1 (el) 2019-07-10

Family

ID=45540947

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20181100743T CY1120438T1 (el) 2011-11-22 2018-07-17 Φαρμακευτικη συνθεση που περιλαμβανει μυο-ινοσιτολη και d-κιρο-ινοσιτολη

Country Status (14)

Country Link
EP (2) EP2782559B1 (el)
CY (1) CY1120438T1 (el)
DK (1) DK2782559T3 (el)
ES (1) ES2631988T3 (el)
HR (1) HRP20181433T1 (el)
IT (1) ITFI20110252A1 (el)
LT (1) LT2782559T (el)
PL (1) PL2782559T3 (el)
PT (1) PT2782559T (el)
RS (1) RS57607B1 (el)
SA (1) SA112340015B1 (el)
SI (1) SI2782559T1 (el)
TW (1) TWI594750B (el)
WO (1) WO2013076121A1 (el)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016020486A1 (en) * 2014-08-08 2016-02-11 Nestec S.A. A combination of myo-inositol and zinc and its use
EP3177277B1 (en) * 2014-08-08 2020-03-11 Société des Produits Nestlé S.A. Myo-inositol and probiotics and uses
BR112017001807B1 (pt) * 2014-08-08 2021-11-03 Société des Produits Nestlé S.A. Composição e combinação para administração materna compreendedo mioinositol e um ou mais probióticos, seu uso, e kit
ITUA20162575A1 (it) 2016-04-13 2017-10-13 S&R Farm S P A Composizione farmaceutica o nutraceutica per l’uso nel trattamento della sindrome dell’ovaio policistico o di malattie o disturbi correlati ad essa
US11898184B2 (en) 2017-09-07 2024-02-13 Sweet Sense Inc. Low glycemic sugar composition
IT201700104446A1 (it) 2017-09-19 2019-03-19 Lo Li Pharma Srl Compositions, uses and methods for treatment of infertility and subfertility
BR112020010343A2 (pt) 2017-11-23 2020-11-10 Biosearch, S.A. método para aumentar taxa de implantação de embrião em um paciente feminino sofrendo de síndrome de ovário policístico
PL238919B1 (pl) 2018-02-28 2021-10-18 Verco Spolka Akcyjna Kompozycja farmaceutyczna zawierająca mio-inozytol i D-chiro- inozytol, do zastosowania w terapeutycznym sposobie obniżania masy ciała u kobiet z zespołem policystycznych jajników
TW202019863A (zh) * 2018-08-22 2020-06-01 瑞士商雀巢製品股份有限公司 組成物及其用途
EP3789018A1 (en) * 2019-09-09 2021-03-10 Servicio Andaluz De Salud Composition and methods for enhancing or promoting the secretion of ghrelin to promote a healthy metabolic aging
IT201900025063A1 (it) 2019-12-20 2021-06-20 Idi Integratori Dietetici Italiani S R L Composizioni gastroresistenti comprendi inositolo e/o estratto di gymnema sylvestre, loro composizioni farmaceutiche e nutraceutiche e loro uso
RU2757220C1 (ru) * 2020-06-03 2021-10-12 Общество с ограниченной ответственностью "ОКТАВА ХОЛДИНГ" Фармацевтическая композиция для профилактики и лечения синдрома поликистозных яичников
AU2021337209A1 (en) 2020-09-04 2023-02-23 Societe Des Produits Nestle Sa Compositions and methods for providing health benefits in an animal
EP4000626A1 (en) * 2020-11-16 2022-05-25 concrete flowers GmbH Pharmaceutical preparation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750348A (en) * 1989-03-08 1998-05-12 The University Of Virginia Patents Foundation Method for detecting insulin resistance
US5906979A (en) * 1998-01-27 1999-05-25 Insmed Pharmaceuticals, Inc. Compositions and methods for treating metabolic diseases characterized by hyperandrogenism and/or anovulation and/or infertility
CZ20021346A3 (cs) * 1999-10-18 2003-06-18 Muscletech Research And Development Inc. Potravinový doplněk pro růst svalové hmoty a síly
JP2006213684A (ja) * 2005-02-07 2006-08-17 Hokko Chem Ind Co Ltd インスリン抵抗性改善に用いられる組成物及び健康用食品
ITRM20070341A1 (it) * 2007-06-20 2008-12-21 Lo Li Pharma Srl Formulazione integrativa inofolic finalizzata al controllo dell'induzione dell'ovulazione in programmi di procreazione medicalmente assistita

Also Published As

Publication number Publication date
PT2782559T (pt) 2018-10-15
DK2782559T3 (en) 2018-08-27
PL2782559T3 (pl) 2018-12-31
EP2782559B1 (en) 2018-06-06
ITFI20110252A1 (it) 2013-05-23
WO2013076121A1 (en) 2013-05-30
LT2782559T (lt) 2018-06-25
EP2782559A1 (en) 2014-10-01
ES2631988T3 (es) 2018-07-12
TW201320992A (zh) 2013-06-01
EP3424497A1 (en) 2019-01-09
ES2631988T1 (es) 2017-09-07
SI2782559T1 (sl) 2018-09-28
RS57607B1 (sr) 2018-11-30
SA112340015B1 (ar) 2016-01-21
HRP20181433T1 (hr) 2018-10-19
TWI594750B (zh) 2017-08-11

Similar Documents

Publication Publication Date Title
CY1120438T1 (el) Φαρμακευτικη συνθεση που περιλαμβανει μυο-ινοσιτολη και d-κιρο-ινοσιτολη
CY1121120T1 (el) Αρυλ- ή ετεροαρυλ-υποκατεστημενες ενωσεις βενζολιου
CY1118680T1 (el) Φαρμακευτικη συνθεση
CY1122186T1 (el) Μεθοδοι θεραπειας καρκινου
EA201400771A1 (ru) Новые производные азетидина, фармацевтические композиции и их применение
UA114087C2 (xx) Похідні піридину
CL2015000942A1 (es) Compuestos de benceno sustituido.
UA116648C2 (uk) Фумарати як проліки та їх застосування при лікуванні різних захворювань
GT201400063A (es) Benzilindazoles sustituidos para uso como inhibidores de la quinasa bub1 en el tratamiento de enfermedades hiperproliferativas
EA201290980A1 (ru) Производные 1-амино-2-циклопропилэтилбороновой кислоты
EA201591166A1 (ru) Ингибиторы аутотаксина
EA201391285A1 (ru) Производные тетрагидрохинолина, полезные в качестве ингибиторов бромодомена
NI201500142A (es) Derivados de 3-acetilamino-1 (fenil-heteroaril-aminocarbonil o fenil-heteroaril-carbonilamino) benceno para el tratamiento de desordenes hiperproliferativos.
GT201400111A (es) Triazolopiridinas sustituidas
UA108101C2 (xx) Похідні n3-заміщених n1-сульфоніл-5-фторпіримідинонів
EA201401081A1 (ru) Циклические амиды в качестве ингибиторов метар-2
CY1123056T1 (el) Νεα μορφη χορηγησης της ρασεκαδοτριλης
UA111744C2 (uk) ЗАМІЩЕНІ ПІРИДОПІРАЗИНИ ЯК ІНГІБІТОРИ Syk
CY1120204T1 (el) Αμορφη στερεα διασπορα για χρηση σε θεραπεια καρκινου του εγκεφαλο
NI201500096A (es) Compuesto químicos
UY34166A (es) Composición farmacéutica oftalmológica tópica que contiene regorafenib
EA201590787A1 (ru) Замещенные пиридопиразины в качестве ингибиторов syk
EA201590932A1 (ru) Композиции, содержащие вортиоксетин и донепезил
PE20150167A1 (es) (r)-nifuratel, su uso para el tratamiento de las infecciones y sintesis de (r) y (s)-nifuratel
ECSP13013075A (es) Método de tratamiento de la fiebre dengue